SG11202002104XA - Topical compositions - Google Patents
Topical compositionsInfo
- Publication number
- SG11202002104XA SG11202002104XA SG11202002104XA SG11202002104XA SG11202002104XA SG 11202002104X A SG11202002104X A SG 11202002104XA SG 11202002104X A SG11202002104X A SG 11202002104XA SG 11202002104X A SG11202002104X A SG 11202002104XA SG 11202002104X A SG11202002104X A SG 11202002104XA
- Authority
- SG
- Singapore
- Prior art keywords
- topical compositions
- topical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762556920P | 2017-09-11 | 2017-09-11 | |
| PCT/US2018/050193 WO2019051368A1 (en) | 2017-09-11 | 2018-09-10 | Topical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202002104XA true SG11202002104XA (en) | 2020-04-29 |
Family
ID=65634484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202002104XA SG11202002104XA (en) | 2017-09-11 | 2018-09-10 | Topical compositions |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200268690A1 (en) |
| EP (1) | EP3681490A4 (en) |
| JP (1) | JP2020533343A (en) |
| KR (1) | KR20200051690A (en) |
| CN (1) | CN111212635A (en) |
| AU (1) | AU2018330314A1 (en) |
| CA (1) | CA3074595A1 (en) |
| IL (1) | IL272944A (en) |
| MX (1) | MX2020002684A (en) |
| SG (1) | SG11202002104XA (en) |
| TW (1) | TW201919608A (en) |
| WO (1) | WO2019051368A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111328280A (en) | 2017-09-11 | 2020-06-23 | 阿托萨治疗学公司 | Methods of making and using endoxifen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8604528D0 (en) * | 1986-02-24 | 1986-04-03 | Ici Plc | Therapeutic agents |
| WO2005044227A1 (en) * | 2003-11-05 | 2005-05-19 | Glenmark Pharmaceuticals Limited | Topical pharmaceutical compositions |
| WO2008067991A2 (en) * | 2006-12-08 | 2008-06-12 | Antares Pharma Ipl Ag | Skin-friendly drug complexes for transdermal administration |
| US8637569B2 (en) * | 2009-10-22 | 2014-01-28 | Api Genesis, Llc | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| US9744177B2 (en) * | 2014-03-10 | 2017-08-29 | Endorecherche, Inc. | Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM |
| AU2016247674A1 (en) * | 2015-04-14 | 2017-10-19 | Atossa Genetics Inc. | Compositions and methods of treatment of breast disorders and estrogen-related disorders |
-
2018
- 2018-09-10 EP EP18853357.4A patent/EP3681490A4/en active Pending
- 2018-09-10 TW TW107131791A patent/TW201919608A/en unknown
- 2018-09-10 CN CN201880066844.2A patent/CN111212635A/en active Pending
- 2018-09-10 JP JP2020514497A patent/JP2020533343A/en active Pending
- 2018-09-10 MX MX2020002684A patent/MX2020002684A/en unknown
- 2018-09-10 WO PCT/US2018/050193 patent/WO2019051368A1/en active Application Filing
- 2018-09-10 KR KR1020207009529A patent/KR20200051690A/en not_active Application Discontinuation
- 2018-09-10 US US16/646,113 patent/US20200268690A1/en not_active Abandoned
- 2018-09-10 SG SG11202002104XA patent/SG11202002104XA/en unknown
- 2018-09-10 CA CA3074595A patent/CA3074595A1/en active Pending
- 2018-09-10 AU AU2018330314A patent/AU2018330314A1/en not_active Abandoned
-
2020
- 2020-02-27 IL IL272944A patent/IL272944A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2020002684A (en) | 2020-09-25 |
| AU2018330314A1 (en) | 2020-03-19 |
| US20200268690A1 (en) | 2020-08-27 |
| EP3681490A1 (en) | 2020-07-22 |
| EP3681490A4 (en) | 2021-11-03 |
| TW201919608A (en) | 2019-06-01 |
| CN111212635A (en) | 2020-05-29 |
| WO2019051368A1 (en) | 2019-03-14 |
| CA3074595A1 (en) | 2019-03-14 |
| IL272944A (en) | 2020-04-30 |
| KR20200051690A (en) | 2020-05-13 |
| JP2020533343A (en) | 2020-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3665237T3 (en) | Compositions | |
| EP3334403A4 (en) | Topical compositions | |
| GB201604484D0 (en) | Topical antibacterial compositions | |
| EP3397239A4 (en) | Topical compositions | |
| GB201703455D0 (en) | Composition | |
| SG11202000615VA (en) | Topical composition | |
| GB201719480D0 (en) | Compositions | |
| GB201707120D0 (en) | Composition | |
| GB201707909D0 (en) | Compositions | |
| IL280533A (en) | Topical composition | |
| GB201700504D0 (en) | Composition | |
| GB201707454D0 (en) | Compositions | |
| PL3609464T3 (en) | Xanthohumol-based compositions | |
| IL277213A (en) | Topical composition | |
| IL268374A (en) | Topical composition | |
| EP3675653C0 (en) | Antimycotoxin composition | |
| GB201707238D0 (en) | Composition | |
| GB201702833D0 (en) | Composition | |
| IL272944A (en) | Topical compositions | |
| EP3359133A4 (en) | Topical antifungal compositions | |
| GB201713160D0 (en) | Topical composition | |
| GB201717712D0 (en) | Compositions | |
| GB201711446D0 (en) | Composition | |
| GB201707920D0 (en) | Composition | |
| EP3322482C0 (en) | Topical ciprofloxacin compositions |